Please use this identifier to cite or link to this item:
Title: Biocompatibility of metal-ion-substituted hydroxyapatite as orthopaedic/dental implant
Authors: Jasmine Widodo
Keywords: DRNTU::Engineering::Chemical engineering::Biotechnology
Issue Date: 2009
Abstract: Metal ions substitution in hydroxyapatite crystal structure is expected to improve biocompatibility and osseointegration to prosthetic implants. Mn(II) and Fe(III) ions substituted hydroxyapatite were synthesized by wet chemical method and ion exchange mechanism with atomic substitution concentration ranged from 1% - 10% and 1% - 5%, respectively. All samples were single-phased and non-stoichiometric, as indicated by various characterization methods including XRD, FTIR, EDX and ICP. Biocompatibility testings were done by using human osteoblast ATCC cell line hFOB 1.19. Cytotoxicity test by extraction method and MTT assay showed that Mn(II) and Fe(III) ions had no cytotoxic effect on the osteoblast cells. In addition, it was established that both Mn(II) and Fe(III) ions improve osteoblast proliferation and activity (confirmed by ALP assay). The optimum ionic substitution concentration was observed to be 5% for both Mn(II) and Fe(III) ions. It was believed that higher metallic ions content led to smaller and less perfect crystal, although not shown in FESEM images among the atomic substitution percentage here. Significant increase in filopodia formation was observed surrounding osteoblast cells which were seeded on both 5% Mn(II) and Fe(III)-ion-substituted hydroxyapatite pellets, indicating good cell-substrate attachment, good intercellular interaction, and improved cell viability.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
  Restricted Access
9.65 MBAdobe PDFView/Open

Page view(s)

checked on Oct 26, 2020


checked on Oct 26, 2020

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.